Despite the evidence that Sephin1 could improve proteostasis, motor neuron survival and motor function, no data currently demonstrates that Sephin1 could reduce TDP-43 cytoplasmic localization or TDP-43 toxicity in ALS models. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.